J.Molner AS (OTSE:MOLNR) EBIT : €-0.93 Mil (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is J.Molner AS EBIT?

J.Molner AS's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was €-0.54 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.93 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. J.Molner AS's annualized ROC % for the quarter that ended in Dec. 2023 was -45.77%. J.Molner AS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -549.24%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. J.Molner AS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -3.82%.

J.Molner AS EBIT Historical Data

The historical data trend for J.Molner AS's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.Molner AS EBIT Chart

J.Molner AS Annual Data

Trend

Dec21

Dec22

Dec23

EBIT

-0.31

-0.55

-0.93

J.Molner AS Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT	-	-0.23	-0.32	-0.39	-0.54

Competitive Comparison of J.Molner AS's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, J.Molner AS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

J.Molner AS's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, J.Molner AS's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where J.Molner AS's EV-to-EBIT falls into.

J.Molner AS EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.93 Mil.

J.Molner AS (OTSE:MOLNR) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

J.Molner AS's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	-1.118 * ( 1 - 0% )	/	( (1.697	+	3.188)	/ 2 )
=	-1.118	/	2.4425
=	-45.77 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	2.339	-	0.21	-	( 0.675	-	max(0, 0.501	-	0.933	+	0.675	))
=	1.697

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	3.131	-	0.418	-	( 0.093	-	max(0, 0.956	-	0.481	+	0.093	))
=	3.188

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

J.Molner AS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-1.082	/	( ( (0.159 + max(0.022, 0))	+	(0.213 + max(-0.312, 0)) )	/	2 )
=	-1.082	/	( ( 0.181	+	0.213 )	/	2 )
=	-1.082	/	0.197
=	-549.24 %

where Working Capital is:

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.118	+	0.009	+	0.119)	-	(0.21	+	0	+	0.014)
=	0.022

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.07	+	0.072	+	0.234)	-	(0.418	+	0	+	0.27)
=	-0.312

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

J.Molner AS's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	-0.929	/	24.326
	=	-3.82 %

J.Molner AS EBIT Related Terms

Thank you for viewing the detailed overview of J.Molner AS's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

J.Molner AS (OTSE:MOLNR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.Molner AS (OTSE:MOLNR) » Definitions » EBIT

Traded in Other Exchanges

N/A

Address

Akadeemia tee 21/5, Harju maakond, Tallinn, EST, 12618

Website

https://www.jmolner.com

J.Molner AS is an Estonia-based company. The company is engaged in research and development in the field of biotechnology. The activities of the Company are divided into two fields: 1) Chemistry analytical and development services for third parties; 2) Development of the Company's own line of generic pharmaceuticals.

J.Molner AS (OTSE:MOLNR) Headlines

No Headlines